Gasco, Beberly A.

HRN: 13-36-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/03/2026
05/10/2026
IV
300mg
Q 8 Hours
DM Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: